<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1726-8958</journal-id>
<journal-title><![CDATA[Revista Médica La Paz]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Méd. La Paz]]></abbrev-journal-title>
<issn>1726-8958</issn>
<publisher>
<publisher-name><![CDATA[Colegio Médico de La Paz]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1726-89582022000100055</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[PARAGANGLIOMA METASTÁSICO PULMONAR CON RESPUESTA A PAZOPANIB. REPORTE DE UN CASO Y REVISIÓN DE LA LITERATURA]]></article-title>
<article-title xml:lang="en"><![CDATA[PULMONARY METASTATIC PARAGANGLIOMA RESPONDING TO PAZOPANIB. CASE REPORT AND LITERATURE REVIEW]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Medina Barrionuevo]]></surname>
<given-names><![CDATA[Rossio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Medina Pérez]]></surname>
<given-names><![CDATA[Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jorge Barroso]]></surname>
<given-names><![CDATA[Henry Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mamani Huanca]]></surname>
<given-names><![CDATA[Aldrin]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Conde Lia]]></surname>
<given-names><![CDATA[Fabian Hanss]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Oncólogo Médico de la Caja de Salud de la Banca Privada  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital de Clínicas Universitario  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Obrero  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af4">
<institution><![CDATA[,CNS  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af5">
<institution><![CDATA[,HODE Oncológico CNS  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2022</year>
</pub-date>
<volume>28</volume>
<numero>1</numero>
<fpage>55</fpage>
<lpage>58</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_arttext&amp;pid=S1726-89582022000100055&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_abstract&amp;pid=S1726-89582022000100055&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_pdf&amp;pid=S1726-89582022000100055&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN: El paraganglioma es un tumor neuroendocrino dependiente del sistema nervioso parasimpático que se encuentra generalmente en localización adrenal y extra-adrenal. En general son de mal pronóstico, siendo el tratamiento primario cirugía, con pobre respuesta a quimioterapia. Presentamos el caso clínico de una paciente con paraganglioma metastásico pulmonar de primario desconocido con respuesta favorable a pazopanib.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT: The paraganglioma is a dependent of the parasympathetic nervous system is generally in adrenal and extra-adrenal neuroendocrine tumor location. They are generally poor prognosis, surgery remains the primary treatment, with poor response to chemotherapy. We report the case of a patient with pulmonary metastatic paraganglioma of unknown primary with a favorable response to pazopanib]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Paraganglioma]]></kwd>
<kwd lng="es"><![CDATA[Pazopanib]]></kwd>
<kwd lng="en"><![CDATA[Paraganlioma]]></kwd>
<kwd lng="en"><![CDATA[Pazopanib]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[Xin]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Primary pulmonary paraganglioma]]></article-title>
<source><![CDATA[Medicine]]></source>
<year>2015</year>
<numero>94</numero>
<issue>94</issue>
<page-range>31: 1-4</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fishbein]]></surname>
<given-names><![CDATA[Lauren]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pheochromocytoma and paraganglioma, genetics, diagnosis and treatment.]]></article-title>
<source><![CDATA[Hematol Oncol Clin]]></source>
<year>2016</year>
<volume>30</volume>
<page-range>135-50</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goffredo]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sosa]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Roman]]></surname>
<given-names><![CDATA[SA.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades.]]></article-title>
<source><![CDATA[J Surg Oncol]]></source>
<year>2013</year>
<volume>107</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>659-64</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Niemeijer]]></surname>
<given-names><![CDATA[ND]]></given-names>
</name>
<name>
<surname><![CDATA[Alblas]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[van Hulsteijn]]></surname>
<given-names><![CDATA[LT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chemotherapy with cyclophosphamide, vincristine and dacarbazine for maligna, paraganglioma and pheochromocytoma: systematic review and meta-analysis.]]></article-title>
<source><![CDATA[Clin Endocrinol (Oxf)]]></source>
<year>2014</year>
<numero>81</numero>
<issue>81</issue>
<page-range>642-51</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[TW]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[YS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas /paragangliomas.]]></article-title>
<source><![CDATA[Cancer]]></source>
<year>2012</year>
<numero>118</numero>
<issue>118</issue>
<page-range>6162-70</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ayala-Ramirez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Chougnet]]></surname>
<given-names><![CDATA[CN]]></given-names>
</name>
<name>
<surname><![CDATA[Habra]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.]]></article-title>
<source><![CDATA[J Clin Endocrinol Metab]]></source>
<year>2012</year>
<numero>97</numero>
<issue>97</issue>
<page-range>4040-50</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miñaña]]></surname>
<given-names><![CDATA[Amanda]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Paraganglioma review: a clinical case.]]></article-title>
<source><![CDATA[Trends in Anaesthesia and Critical Care]]></source>
<year>2014</year>
<numero>4</numero>
<issue>4</issue>
<page-range>159-64</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[gonzález]]></surname>
<given-names><![CDATA[Ricardo]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of multicentric paragangliomas: review of 24 patients with 60 tumors]]></article-title>
<source><![CDATA[Head &amp; Neck]]></source>
<year>2015</year>
<page-range>1-10</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
